Pancreatic Cancer Collective awards Dana-Farber Cancer Institute researchers “New Therapies Challenge” grant
Dana-Farber Cancer Institute• $1 million in initial funding to evaluate DNA repair inhibitors in pancreatic cancer • Aim to accelerate pancreatic cancer research and improve patient outcomes for pancreatic cancer